Open AccessInvestigating treatment response and immune profile in association with pattern identification in NSCLC patients scheduled for immune checkpoint inhibitor monotherapy (HARMONY study)
Author(s) -
JungHee Jang,
Hyeong Joon Jun,
Yujin Choi,
Jin Chul Kim,
Ho G. Jang,
Sang-Min Park,
Ojin Kwon,
ChangMin Choi,
Seung Joon Kim,
Jeong Yoon Choi,
Ji Woong Son,
Seung Hyeun Lee,
TaeWon Jang,
Seong Hoon Yoon,
JeongSeon Ryu,
Jun Hyeok Lim,
Seunghun Jang,
IlSeok Oh,
Sung Yong Lee,
Mi-Kyung Jeong
Publication year - 2022
Publication title -
medicine, case reports and study protocols
Language(s) - English
Resource type - Journals
ISSN - 2691-3895
DOI - 10.1097/md9.0000000000000247
Subject(s) - pembrolizumab , atezolizumab , immune system , oncology , medicine , clinical endpoint , lung cancer , immune checkpoint , biomarker , survival analysis , immunotherapy , immunology , clinical trial , biology , biochemistry